---

Insulin resistance and neurodegenerative diseases

Full Text PDF Share on Facebook Share on Twitter

---

Review Article

Author Details : Akshmita Gairola, Anil Kumar Prajapati*, Mustakim Mansuri

Volume : 9, Issue : 2, Year : 2024

Article Page : 87-90

https://doi.org/10.18231/j.ijcaap.2024.013

Suggest article by email

Get Permission

Abstract

Insulin resistance is a condition where normal or elevated insulin levels fail to elicit the expected biological response, with significant implications for neurodegenerative diseases such as Alzheimer's disease (AD) and Parkinson's disease (PD). Despite extensive research, the precise cellular mechanisms driving insulin resistance and its role in neurodegeneration remain elusive. Insights into insulin signaling dysregulation, amyloid-beta accumulation, neuroinflammation, and impaired mitochondrial function shed light on the complex interplay between insulin resistance and neurodegeneration. Various therapeutic strategies targeting insulin resistance, including insulin interventions, GLP-1 analogs, intranasal insulin, and lifestyle interventions, offer promising avenues for mitigating disease progression. This review provides a comprehensive overview of insulin resistance and its association with neurodegenerative disorders, highlighting key molecular and cellular insights, therapeutic approaches, and future directions.

Keywords: Insulin resistance, Neurodegeneration, Alzheimer's disease, Parkinson disease

How to cite : Gairola A, Prajapati A K, Mansuri M, Insulin resistance and neurodegenerative diseases. IP Int J Compr Adv Pharmacol 2024;9(2):87-90

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.